<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://stocktwits.com/sitemap/rss_feed.xml</title><link>https://stocktwits.com/sitemap/rss_feed.xml</link><description>Individual feed output.</description><lastBuildDate>Fri, 21 Nov 2025 10:38:13 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Eli Lilly Joins Tech Players In The $1T Market Capitalization Club</title><link>https://stocktwits.com/news-articles/markets/equity/eli-lilly-joins-tech-players-in-the-one-trillion-market-capitalization-club/cLPMrffREOA</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>The company’s GLP-1 drugs, Zepbound and Mounjaro, have driven investor appetite and pushed its share price by about 40% this year.</description><pubDate>Fri, 21 Nov 2025 15:23:12 GMT</pubDate></item><item><title>Michael Saylor Says Index Classification ‘Doesn’t Define’ MSTR Amid MSCI Exclusion Concerns</title><link>https://stocktwits.com/news-articles/markets/equity/saylor-says-index-classification-doesnt-define-mstr-amid-msci-exclusions/cLPMq8QREOq</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>In a post on X, MSTR’s executive chairman stated that Strategy is an operating company, not a fund, trust, or holding company.</description><pubDate>Fri, 21 Nov 2025 14:59:27 GMT</pubDate></item><item><title>Arthur Hayes Says Bitcoin Nearing Bottom, But AI Stocks Need To ‘Crater’ First</title><link>https://stocktwits.com/news-articles/markets/cryptocurrency/arthur-hayes-says-bitcoin-nearing-bottom-but-ai-stocks-need-to-crater/cLPMqlnREOp</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>In a broadcast on X earlier this week, Hayes predicted that Bitcoin could reach $500,000 in 2026 if quantitative easing occurs.</description><pubDate>Fri, 21 Nov 2025 14:55:11 GMT</pubDate></item><item><title>Novo’s Obesity Drug Patients Granted Compensation In Denmark Over Rare Eye Disease Linked To Wegovy, Ozempic</title><link>https://stocktwits.com/news-articles/markets/equity/novo-obesity-drug-patients-granted-compensation-in-denmark-over-rare-eye-disease-linked-to-wegovy-ozempic/cLPMqfwREOY</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>The four claimants will receive a combined 800,000 kroner, though that figure may rise, Danish Patient Compensation said on Friday.</description><pubDate>Fri, 21 Nov 2025 14:46:58 GMT</pubDate></item><item><title>Why Did NFE Stock Fall 14% Today?</title><link>https://stocktwits.com/news-articles/markets/equity/why-did-nfe-stock-fall-14-today/cLPMqawREOo</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>In an SEC filing on Friday, NFE's management raised concerns over the company’s ability to continue as a going concern.</description><pubDate>Fri, 21 Nov 2025 14:45:34 GMT</pubDate></item></channel></rss>